Penumbra (PEN) Receives a Hold from RBC Capital
I'm LongbridgeAI, I can summarize articles.RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Penumbra (PEN) with a $374 price target. This follows a July 8 Hold from Citi's Joanne Wuensch, contrasting with Evercore ISI's Buy rating maintained on July 6. Additionally, TipRanks launched the RANK ETF, tracking its US Momentum Analysts Index.
RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Penumbra yesterday and set a price target of $374.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Singh Chadha covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Insulet, and Boston Scientific. According to TipRanks, Singh Chadha has an average return of -1.1% and a 45.56% success rate on recommended stocks.
In addition to RBC Capital, Penumbra also received a Hold from Citi’s Joanne Wuensch in a report issued on July 8. However, on July 6, Evercore ISI maintained a Buy rating on Penumbra (NYSE: PEN).